The Future is Bright for Stem Cell Treatments
Considering the many emerging research studies on possible cord blood and cord tissue stem cell use, the future of stem cell treatments is very bright. Only the surface has been scratched when it comes to discovering the potential of these cells to treat diseases and disorders. New technologies that allow for the expansion of cord blood cells means that effective autologous therapy will be achievable well into adulthood. Additionally, research has shown that cord blood stem cells can also be effectively used for regeneration or repair, of non-hematopoietic tissues, such as the repair of joint damage through cartilage regeneration. Studies have also demonstrated that these cells are effective at modulating/reducing inflammation, and in the treatment of neurological disorders (ie. ALS, Alzheimer’s Disease, Stroke) that can occur later in life. Keeping up with the latest news inspires hope in the future.
Stem Cells Offer New Ways to Repair Joints
The normal tendon, when we repair it, heals with scar tissue. That’s where the stem cells come in. Instead of scar tissue taking over, the hope is that the stem cells, which have the ability to differentiate, will help generate more normal anatomy.
First Clinical Trial Using Stem Cells to Treat Alzheimer’s Disease
A new clinical trial at the University of Miami Miller School of Medicine will be the first in the U.S. to focus on using mesenchymal stem cells (MSCs) to treat Alzheimer’s disease. MSCs are increasingly being utilized in regenerative medicine for a wide range of conditions including heart and kidney disease, ALS, wound healing and autoimmune diseases. The umbilical cord is a rich source of mesenchymal stem cells.
Congress Approves Stem Cell Act Reauthorization
Legislation reauthorizing the Stem Cell Therapeutic and Research Act has been overwhelmingly passed by both the U.S. Senate and House of Representatives. The bill authorizes $23 million per year for the next five years for cord blood inventory growth and diversity. The Cord Blood Association, together with the National Marrow Donor Program (NMDP), worked tirelessly with members of Congress this year and testified in support of the legislation that totals $115 million for five years for the National Cord Blood Inventory (NCBI) and $150 million in that same period for blood and marrow transplant programs through the C.W. Bill Young Transplantation Program.
Patented Stem Cell Therapy to Treat Heart Failure Uses Cord Blood Stem Cells
Creative Medical Health Inc. was issued the patent titled, “Combination Therapy of Cardiovascular Disease.” The patent covers the use of adult stem cells such as cord blood and mesenchymal stem cells in combination with modulation of oxidative stress in treatment of heart failure. Additionally, the patent covers in-treatment assessment of oxidative stress so as to give doctors ability to personalize the treatment protocol to the particular needs of the patient.
Upbeat Update from Duke on Stem Cell Autism Trial
This week at the World Stem Cell Summit, Dr. Joanne Kurtzberg, Pediatric Bone Marrow Transplant Specialist at Duke University Medicine, gave an encouraging update on the cord blood stem cell trial to treat autism.
Umbilical Stem Cells Help Retinal Neurons Grow
Stem cell therapy has shown immense potential for the treatment of neurological disorders. Now, research has shown that stem cells found in human umbilical cord tissue could one day be used to treat degenerative eye diseases.
Blood of world's oldest woman hints at limits of life
Researchers have now examined her blood and other tissues to see how they were affected by age. What they found suggests, as we could perhaps expect, that our lifespan might ultimately be limited by the capacity for stem cells to keep replenishing tissues day in day out.
Stem cell research is currently a subject of keen interest for major research institutions.
According to a study by Johns Hopkins researchers, specially engineered "helper cells" transplanted along with stem cells can dole out growth factors to increase the stem cells' endurance. The study is believed to be the first to test the helper-cell tactic, which hopefully someday will help to overcome a major barrier to successful stem cell transplants.
New research by UC Davis centers on regenerating tissue to repair damaged neural tissue.
Stem cell technology has long offered the hope of regenerating tissue to repair broken or damaged neural tissue. Findings from a team of UC Davis investigators have brought this dream a step closer by developing a method to generate functioning brain cells that produce myelin.
FDA Approves Multiple Sclerosis Stem Cell Trial
After more than a decade of research, a groundbreaking study using stem cells to treat multiple sclerosis (MS) has been approved by the Food and Drug Administration. If successful, scientists believe it may one day lead to a cure for the autoimmune system disease.